Advancing Premium Adoption Through Adjustability with Matt Kaufman, MD

Even the smallest diopter can make a big difference in refractive outcomes. That’s why Matt Kaufman, MD, of Eye Health Northwest in Portland, OR, says adopting the Light Adjustable Lens™ (LAL®) has elevated results for both his patients and his team. From reducing stress to raising premium adoption rates, see how the LAL has opened […]

Navigating Practice Optimization and Patient Education with the Light Adjustable Lens™ with Advanced Eye Care, SC

Successful optimization of new technology requires two crucial components: an aligned staff and educated patients. Dylan Stevens, MD, and Christine Sykora, practice administrator at Advanced Eye Care, SC, share their strategy for getting their practice on board with the Light Adjustable Lens™ (LAL®). They also discuss how their partnership with Chris Bonsall from Navigate Patient […]

Hear From Your Peers: Light Adjustable Lens™ Success Stories

See how the Light Adjustable Lens™ (LAL®) is transforming practices and patient outcomes. Hear firsthand from eye care specialists who have successfully integrated the Light Adjustable Lens into their practice. Guest Speakers I. Paul Singh, MD The Eye Centers of Racine & Kenosha Evan Schoenberg, MD Georgia Eye Partners Joaquin De Rojas, MD Center for […]

Enhancing Practice Growth and Patient Care with Greg Henson, COO

Greg Henson shares how the team at UOA successfully navigated integrating the Light Adjustable Lens™ (LAL®) technology into their practices. He highlights the positive impact on both patient satisfaction and practice operational performance, as well as the importance of having a supportive team to ensure a smooth rollout of new technologies.

Optimizing Light Adjustable Lens™ Outcomes Through Ocular Surface Management with Paul Karpecki, OD, FAAO

Paul Karpecki, OD talks about his extensive clinical experience and integrating advanced technology such as the Light Adjustable Lens™ (LAL®). Dr. Karpecki emphasizes the importance of a healthy ocular surface for optimal surgical outcomes. He discusses the implementation of the Light Adjustable Lens in clinical practices, the significance of patient education and expectation management, and […]

Delivering Quality of Vision Through a Team-Based Approach at the Eye Centers of Racine & Kenosha

I. Paul Singh, MD, Jessica Schiffbauer, OD, and Jeff Banas, OD discuss collaborative care with the Light Adjustable Lens™ (LAL®). They talk about the importance of maintaining high-quality vision and tailoring the lens to each patient’s specific needs. The optometric team shares specific patient stories about postoperative adjustments and their approach to ensuring patient-driven outcomes. […]

Setting Expectations and Driving Premium Lens Adoption with Bridget A. Sundell, MD

Bridget A. Sundell, MD, takes a team-based approach to surgery with the Light Adjustable Lens™ (LAL®). Dr. Sundell explains her process for setting realistic expectations with patients regarding this premium technology and guiding them through the journey. She shares how she educates patients on the lens’ long-term value. Dr. Sundell mentions how the Light Adjustable […]

LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

The Light Adjustable Lens provides optimized vision for patient satisfaction.2

Light Adjustable Lens patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

Since the Light Adjustable Lens is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

LAL patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The Light Adjustable Lens offers LASIK-like accuracy in cataract surgery.2,3

92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).

Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

The Light Adjustable Lens corrects as low as 0.50 D of astigmatism, which is the lowest level approved to be treated.

The ability to treat 0.50 D of postoperative cylinder makes the Light Adjustable Lens the only IOL in the United States approved to correct this level of vision-altering astigmatism. Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.1